Back to search

Poland· PL-100381230

Atracurium Kalceks

A atracurium product containing atracurium, registered in Poland by AS Kalceks. The same ATC class is registered in 13 of our 19 countries.

ATC M03AC04

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedAtracurium KalceksATCM03AC04REGISTER NO.PL-100381230PACKS LISTED2CHECKEDSeptember 27, 2026

Where it is registered

Atracurium is registered in 13 of 19 countries.

Countries holding a registration under ATC M03AC04 (atracurium), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 8 of them publish a price we can compare per daily dose

Atracurium · ATC M03AC04

13 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Atracurium
Manufacturer
AS Kalceks
Country
Poland (PL)
ATC code
M03AC04
ATC class
Atracurium
Defined daily dose
38.5 mg, P
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

  • gtin
    04750341001995
  • gtin
    04750341001988

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

60 interactions on record for atracurium.

Graded by severity as the source publishes them — 12 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Atracurium · interactions on record

60 records

  • 12 severe
  • 44 moderate
  • 4 minor

Most severe, free to view

  • NeomycinA07AA01severe
  • StreptomycinA07AA04severe
  • Polymyxin BA07AA05severe
  • ParomomycinA07AA06severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e103b6b1-0ad7-4f75-8427-1799a53eea61
GET /v1/drugs/e103b6b1-0ad7-4f75-8427-1799a53eea61?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Roztwór do wstrzykiwań",
  "source": "urpl",
  "strength": "10 mg/ml",
  "packaging": "04750341001995 ¦ Lz ¦ 126173\n5 amp. 5 ml\n04750341001988 ¦ Lz ¦ 126174\n5 amp. 2,5 ml",
  "substance": "Atracurium 10 mg/ml",
  "common_name": "Atracurium",
  "pl_product_id": "100381230",
  "pozwolenie_nr": "24531",
  "auth_procedure": "DCP",
  "authorisation_validity": "Bezterminowe"
}

See everything about atracurium.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.